Skip to content

Clinical study of Gegen Heisu Decoction combined with Huolongtin in treating thin endometrium of kidney deficiency and blood stasis type

Clinical study of Gegen Heisu Decoction combined with Huolongtin in treating thin endometrium of kidney deficiency and blood stasis type

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025001148
Enrollment
Unknown
Registered
2025-06-11
Start date
2023-08-10
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thin endometrium

Interventions

Traditional Chinese medicine group:Starting from day 5 of the menstrual cycle, patients take Gengen Heisu Decoction (containing 30g Pueraria lobata, 20g Perilla stem, etc.) orally once daily until the
Medicine Group:Start using Fenmatong (estradiol tablets and estradiol and dydrogesterone tablets) on the first day of menstruation, once a day, and stop using it before the next menstruation

Sponsors

Yongjia Country Traditional Chinese Medicine Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: (1) Meet the diagnostic standards of traditional Chinese medicine and Western medicine; (2) Women aged 20-40; (3) The duration of the disease exceeds 3 menstrual cycles; (4) do not use any hormone drugs or Chinese medicine within three months before treatment; (5) Voluntarily participate in this study and sign the informed consent.

Exclusion criteria

Exclusion criteria: (1) be less than 20 years old or more than 40 years old; (2) secondary irregular menstruation caused by other diseases or taking drugs; (3) gynecological diseases such as ovarian cyst and cervicitis; (4) during pregnancy and lactation; (5) perimenopause; (6) complicated with heart brain kidney and other important organ diseases; (7) with malignant tumor (8) using oral hormone drugs or contraceptives in the past 3 months; (9) those with mental illness or mental disorder who cannot express themselves normally. (10) with infectious and non-infectious skin diseases special skin diseases skin damage local skin wounds or severe local soft tissue edema.

Design outcomes

Primary

MeasureTime frame
Total menstrual volume;Endometrial thickness and endometrial blood flow;

Secondary

MeasureTime frame
therapeutic evaluation;safety evaluation;TCM syndrome score;

Countries

China

Contacts

Public Contactlin xia

Yongjia Country Traditional Chinese Medicine Hospital

linxiawz12@163.com+86 131 0232 0361

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026